×
About 44,733 results

ALLMedicine™ Fatty Liver Center

Research & Reviews  21,411 results

Relationship between triglyceride glucose index and the incidence of non-alcoholic fatt...
https://doi.org/10.1136/bmjopen-2020-039804
BMJ Open; Huanan C, Sangsang L et. al.

Nov 28th, 2020 - Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of liver-related diseases but relationship between triglyceride glucose (TyG) and NAFLD in the elderly is not reported yet. In this study, we investigated the role of TyG index f...

Metabolic Consequences of Solid Organ Transplantation.
https://doi.org/10.1210/endrev/bnaa030
Endocrine Reviews; Bhat M, Usmani SE et. al.

Nov 28th, 2020 - Metabolic complications affect over 50% of solid organ transplant recipients. These include post-transplant diabetes, non-alcoholic fatty liver disease, dyslipidemia, and obesity. Pre-existing metabolic disease is further exacerbated with immunosu...

Inhibition of ACC causes malformations in rats and rabbits: comparison of mammalian fin...
https://doi.org/10.1093/toxsci/kfaa169
Toxicological Sciences : an Official Journal of the Society of Toxicology; Catlin NR, Bowman CJ et. al.

Nov 28th, 2020 - Acetyl-CoA carboxylase (ACC) is an enzyme within the de novo lipogenesis (DNL) pathway and plays a role in regulating lipid metabolism. Pharmacologic ACC inhibition has been an area of interest for multiple potential indications including oncology...

Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Nonalcoholic Fatty...
https://doi.org/10.2174/1871530320999201126202706
Endocrine, Metabolic & Immune Disorders Drug Targets; Li J, Zhao Y et. al.

Nov 27th, 2020 - Many published studies attempted to elucidate the implication of glucokinase regulator gene (GCKR) polymorphisms in the susceptibility to nonalcoholic fatty liver disease (NAFLD), but the results among them were still with controversy. This meta-a...

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam st...
https://doi.org/10.1111/apt.16177
Alimentary Pharmacology & Therapeutics REFERENCES; Zhang X, Mens MMJ et. al.

Nov 27th, 2020 - Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD. To investigate the potentia...

see more →

Guidelines  51 results

Latin American Association for the study of the liver (ALEH) practice guidance for the ...
https://doi.org/10.1016/j.aohep.2020.09.006
Annals of Hepatology; Arab JP, Dirchwolf M et. al.

Oct 8th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052356/
Frontiers in Pharmacology; Gisondi P,et al

Feb 24th, 2020 - Psoriasis is a chronic, systemic immune-mediated disease characterized by development of erythematous, indurated, scaly, pruritic plaques on the skin. Psoriasis is frequently associated to comorbidities, including psoriatic arthritis, cardiovascul...

Non-alcoholic fatty liver disease
https://ghr.nlm.nih.gov/condition/non-alcoholic-fatty-liver-disease
NIH - Genetics Home Reference;

Feb 10th, 2020 - Non-alcoholic fatty liver disease (NAFLD) is a buildup of excessive fat in the liver that can lead to liver damage resembling the damage caused by alcohol abuse, but that occurs in people who do not drink heavily.

ACG Clinical Guideline: Hereditary Hemochromatosis
https://journals.lww.com/ajg/Fulltext/2019/08000/ACG_Clinical_Guideline__Hereditary_Hemochromatosis.11.aspx
Kowdley,K.,et al

Aug 1st, 2019 - Hereditary hemochromatosis (HH) is one of the most common genetic disorders among persons of northern European descent. There have been recent advances in the diagnosis, management, and treatment of HH. The availability of molecular diagnostic tes...

Nonalcoholic Fatty Liver Disease & NASH
https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash?dkrd=hispt0394

May 7th, 2019 - Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic steatohepatitis (NASH) is a type of NAFLD. If you have NASH, you have inflammation and liver cell damage, along with fat in your liver.

see more →

Clinicaltrials.gov  22,173 results

Relationship between triglyceride glucose index and the incidence of non-alcoholic fatt...
https://doi.org/10.1136/bmjopen-2020-039804
BMJ Open; Huanan C, Sangsang L et. al.

Nov 28th, 2020 - Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of liver-related diseases but relationship between triglyceride glucose (TyG) and NAFLD in the elderly is not reported yet. In this study, we investigated the role of TyG index f...

Metabolic Consequences of Solid Organ Transplantation.
https://doi.org/10.1210/endrev/bnaa030
Endocrine Reviews; Bhat M, Usmani SE et. al.

Nov 28th, 2020 - Metabolic complications affect over 50% of solid organ transplant recipients. These include post-transplant diabetes, non-alcoholic fatty liver disease, dyslipidemia, and obesity. Pre-existing metabolic disease is further exacerbated with immunosu...

Inhibition of ACC causes malformations in rats and rabbits: comparison of mammalian fin...
https://doi.org/10.1093/toxsci/kfaa169
Toxicological Sciences : an Official Journal of the Society of Toxicology; Catlin NR, Bowman CJ et. al.

Nov 28th, 2020 - Acetyl-CoA carboxylase (ACC) is an enzyme within the de novo lipogenesis (DNL) pathway and plays a role in regulating lipid metabolism. Pharmacologic ACC inhibition has been an area of interest for multiple potential indications including oncology...

Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Nonalcoholic Fatty...
https://doi.org/10.2174/1871530320999201126202706
Endocrine, Metabolic & Immune Disorders Drug Targets; Li J, Zhao Y et. al.

Nov 27th, 2020 - Many published studies attempted to elucidate the implication of glucokinase regulator gene (GCKR) polymorphisms in the susceptibility to nonalcoholic fatty liver disease (NAFLD), but the results among them were still with controversy. This meta-a...

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam st...
https://doi.org/10.1111/apt.16177
Alimentary Pharmacology & Therapeutics REFERENCES; Zhang X, Mens MMJ et. al.

Nov 27th, 2020 - Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD. To investigate the potentia...

see more →

News  1,079 results

Even Mild NAFLD Associated With Higher Mortality
https://www.medscape.com/viewarticle/941350

Nov 22nd, 2020 - NEW YORK (Reuters Health) - All stages of nonalcoholic fatty liver disease (NAFLD) are associated with significantly increased overall mortality, and this risk increases progressively with worsening disease, Swedish researchers have found. Deaths ...

NAFLD Prevalence Rising Among Children but Many Undiagnosed
https://www.medscape.com/viewarticle/941319

Nov 19th, 2020 - (Reuters Health) - The incidence of nonalcoholic fatty liver disease (NAFLD) is rising among children, but not all youth with obesity are getting recommended screening, a study in California suggests. Researchers examined electronic health record ...

Metabolic Disease Linked to Instability of the Gut Microbiome
https://www.staging.medscape.com/viewarticle/941175

Nov 17th, 2020 - NEW YORK (Reuters Health) - The gut microbiome appears to be largely stable over time in most people, but metabolic disorders such as fatty liver disease and diabetes are associated with increased microbial instability, according to new research. ...

Metabolic Disease Linked to Instability of the Gut Microbiome
https://www.medscape.com/viewarticle/941175

Nov 17th, 2020 - NEW YORK (Reuters Health) - The gut microbiome appears to be largely stable over time in most people, but metabolic disorders such as fatty liver disease and diabetes are associated with increased microbial instability, according to new research. ...

Lipid Profiles Distinguish NAFLD With and Without Obesity
https://www.medscape.com/viewarticle/940973

Nov 12th, 2020 - Both obese and nonobese individuals can develop nonalcoholic fatty liver disease (NAFLD), and lipid profiles were effective predictors in both groups, based on data from a cross-sectional study of 361 individuals. Given the strong association betw...

see more →

Patient Education  19 results see all →